AstraZeneca announces innovative cooperation with China Resources Gas and Everbright Environment to help its production and supply bases in China achieve decarbonization
HYHY
发表于 2024-3-29 20:41:57
4065
0
0
On March 29th, AstraZeneca's official WeChat account reported that on March 27th, biopharmaceutical company AstraZeneca signed its first ten-year renewable energy contract with China Resources Gas. AstraZeneca's green heating at its production and supply base in Wuxi, Jiangsu will help AstraZeneca China achieve greenhouse gas emissions reduction of up to 80% in Scope 1 and Scope 2 in China, and help the entire healthcare system achieve decarbonization. China Resources Gas will cooperate with Everbright Environment to provide biomethane and biomethane based steam to AstraZeneca's Wuxi production and supply base, in order to achieve decarbonization in drug production and supply processes.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- A sharp drop of 87%! Maserati will only sell over 30 units in China in September! Has the 'Sports Car Queen' fallen from grace?
- Honda accelerates its electrification layout in China, with joint ventures intensively deploying electric vehicles
- Pfizer and CR Pharma reach strategic partnership on four mature drugs
- Merck PD-1 inhibitor pembrolizumab's fourth lung cancer indication approved in China
- Hegang partners with BHP to promote decarbonization technology innovation and development in the steel industry value chain
- The CEO of the world's fourth largest car company, Stellantis, has resigned and adjusted the person in charge of related business in China
- The CEO of the world's fourth largest car company, Stellantis, has resigned and adjusted the person in charge of related business in China
- Nvidia expands in China against the trend, attracting talent and adding hundreds of R&D personnel in one year
- Apple is rumored to have preliminary discussions with Tencent and ByteDance to consider embedding their AI models into iPhones sold in China
- Sanofi's BTK inhibitor is declared for market in China